InBrain Pharma
Latest round
- Seed
Last raised
- Feb 2019
Total raised
- $1.4M
Investors
- 2
About InBrain Pharma
InBrain Pharma, located in France, is a biotechnology company focused on developing innovative therapies for neurological disorders, particularly advanced Parkinson's disease.Founded in 2018, InBrain Pharma specializes in therapeutic solutions for neurological conditions.2 mn.InBrain Pharma's core product is A-Dopamine, a revolutionary device-aided therapy designed for the continuous administration of dopamine directly into the brains of patients suffering from advanced Parkinson's disease. This innovative approach addresses significant limitations associated with traditional oral dopamine treatments, such as systemic side effects and inadequate therapeutic efficacy due to dosage restrictions. The therapy is specifically targeted at patients experiencing severe and refractory motor complications due to L-dopa oral treatment, facilitating a more effective and safe management of their symptoms.InBrain Pharma's revenue model is structured around partnerships with healthcare institutions and the distribution of its proprietary A-Dopamine therapy. The company collaborates with academic and private entities to facilitate the delivery of its innovative treatment, potentially engaging in B2B transactions with hospitals and specialized clinics that treat neurodegenerative diseases. Revenue is generated through the sale of A-Dopamine devices and associated services, which may include training for healthcare providers and ongoing support. The structure of these transactions involves upfront costs for the devices, with additional charges for any supplementary services offered. The company plans to expand its presence in North America and Europe, targeting regions with high needs for advanced neurodegenerative care.
Who invested in InBrain Pharma
2 investors across 1 round
See all investors in InBrain Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 15, 2019
Amount
$1.4M
Investors
Questions about InBrain Pharma
Who invested in InBrain Pharma?
InBrain Pharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InBrain Pharma raised?
InBrain Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did InBrain Pharma last raise money?
InBrain Pharma's most recent round on record is a Seed, in Feb 2019.
What does InBrain Pharma do?
InBrain Pharma, located in France, is a biotechnology company focused on developing innovative therapies for neurological disorders, particularly advanced Parkinson's disease.
Where is InBrain Pharma headquartered?
InBrain Pharma is headquartered in Loos, France.
Which VCs invest in companies like InBrain Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at InBrain Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like InBrain Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.